Evidence map›Paper›PMID 27095758›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2016

[HCV infection and specific T lymphocyte immunity].

J J Shi, J Y Zhang, X X Zhang, F S Wang

Abstract readReview
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J J ShiInfectious Disease Diagnosis, Treatment and Research Center, 302 Military Hospital of China-Peking University Teaching Hospital, Beijing 100039, China.
J Y ZhangInfectious Disease Diagnosis, Treatment and Research Center, 302 Military Hospital, Beijing 100039, China.
X X ZhangInfectious Disease Diagnosis, Treatment and Research Center, 302 Military Hospital of China-Peking University Teaching Hospital, Beijing 100039, China.
F S WangInfectious Disease Diagnosis, Treatment and Research Center, 302 Military Hospital, Beijing 100039, China; Infectious Disease Diagnosis, Treatment and Research Center, 302 Military Hospital of China-Peking University Teaching Hospital, Beijing 100039, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adaptive immunity, especially the cellular immunity mediated by T lymphocytes, plays an important role in the body's fight against hepatitis C virus (HCV) infection. The clearance of HCV requires a strong, sustained, and multi-epitope response from specific T lymphocytes, and the dysfunction of specific T lymphocytes is the major reason for chronic infection. Effective treatment can restore the function of specific T lymphocytes to a certain extent. This article reviews the features and related mechanisms of immune response from specific T lymphocytes when the prognosis of patients with HCV infection is different.

Indexed as

HepacivirusHepatitis CHepatitis C, ChronicHumansImmunity, CellularT-Lymphocytes

Identifiers

PMID27095758
PMCPMC12770263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.